Product Information

CLOTRIMAZOLE-BETAMETHASONE CRM is a generic product labeled by Actavis Pharma, Inc., priced at $0.1711 per GM under NDC 00472037945. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Aug 2, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLOTRIMAZOLE-BETAMETHASONE CRM

Clotrimazole and Betamethasone Dipropionate
$0.1711per GM

Strength

.5; 10 mg/g; mg/g

NDC

00472037945

Classification

Generic

Dosage Form

CREAM

Route

TOPICAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA076002

FDA Approved

8/2/2002

TE Code

AB

On Market Since

12/16/2003

Pharmacological Classes

Azole Antifungal
Azoles
Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for CLOTRIMAZOLE-BETAMETHASONE CRM has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 78.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1711 per GM
All-time high$0.8300 (Jan 15, 2014)
All-time low$0.1494 (Oct 18, 2023)
52-week high$0.1878
52-week low$0.1711
Median price$0.2380
Average price$0.3239
Largest weekly change+23.8% (Nov 20, 2024)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-3.9%

3M

-8.1%

6M

-8.2%

1Y

-8.1%

3Y

+14.5%

5Y

-7.2%

All

-78.5%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLOTRIMAZOLE-BETAMETHASONE CRM?

The current National Average Drug Acquisition Cost (NADAC) for CLOTRIMAZOLE-BETAMETHASONE CRM, manufactured by Actavis Pharma, Inc., is $0.1711 per GM (NDC 00472037945), effective Nov 11, 2026.

How has the price of CLOTRIMAZOLE-BETAMETHASONE CRM changed over time?

Over the history we have for it, the NADAC for CLOTRIMAZOLE-BETAMETHASONE CRM has declined 78.5%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CLOTRIMAZOLE-BETAMETHASONE CRM?

Since Nov 28, 2013, the NADAC for CLOTRIMAZOLE-BETAMETHASONE CRM has ranged from a low of $0.1494 (Oct 18, 2023) to a high of $0.8300 (Jan 15, 2014), with a median of $0.2380 per GM.

Are there cheaper alternatives to CLOTRIMAZOLE-BETAMETHASONE CRM?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLOTRIMAZOLE-BETAMETHASONE CRM in a comparable dosage form, but none are currently priced below it.

Who manufactures CLOTRIMAZOLE-BETAMETHASONE CRM?

CLOTRIMAZOLE-BETAMETHASONE CRM (NDC 00472037945) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.